Dara L Aisner

Dara L Aisner

UNVERIFIED PROFILE

Are you Dara L Aisner?   Register this Author

Register author
Dara L Aisner

Dara L Aisner

Publications by authors named "Dara L Aisner"

Are you Dara L Aisner?   Register this Author

90Publications

3802Reads

8Profile Views

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

J Thorac Oncol 2019 Sep 20;14(9):1666-1671. Epub 2019 Jun 20.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708730PMC
September 2019

Wake Up and Smell the Fusions: Single-Modality Molecular Testing Misses Drivers.

Clin Cancer Res 2019 Aug 3;25(15):4586-4588. Epub 2019 Jun 3.

Department of Pathology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1361DOI Listing
August 2019

Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.

J Mol Diagn 2019 Jul 7;21(4):553-571. Epub 2019 May 7.

Department of Pathology, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15251578183059
Publisher Site
http://dx.doi.org/10.1016/j.jmoldx.2019.03.008DOI Listing
July 2019

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.

J Vis Exp 2019 Jul 5(149). Epub 2019 Jul 5.

Department of Pathology, University of Colorado - Anschutz Medical Campus;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59895DOI Listing
July 2019

Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.

Mol Carcinog 2019 05 16;58(5):666-673. Epub 2019 Jan 16.

Department of Pathology, School of Medicine, Molecular Biology Program, Medical Scientist Training Program, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637962PMC
May 2019

Ready or Not, Here I Come: Inflammatory Myofibroblastic Tumors With Kinase Alterations Revealed Through Molecular Hide and Seek.

J Thorac Oncol 2019 May;14(5):758-760

Department of Pathology, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.006DOI Listing
May 2019

DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer.

J Thorac Oncol 2019 Apr 9;14(4):737-741. Epub 2019 Jan 9.

Department of Pathology, Division of Pathology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.020DOI Listing
April 2019

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.

J Thorac Oncol 2018 10 20;13(10):1474-1482. Epub 2018 Jun 20.

Department of Medicine - Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286810PMC
October 2018

Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.

JAMA 2018 08;320(5):445-446

University of Colorado Cancer Center, University of Colorado, Denver, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.10096DOI Listing
August 2018

The Revised College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline: A Step Forward for Molecular Cytopathology.

Authors:
Dara L Aisner

Arch Pathol Lab Med 2018 06 29;142(6):684-685. Epub 2018 Mar 29.

From the Department of Pathology, University of Colorado School of Medicine, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2018-0081-EDDOI Listing
June 2018

Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation.

Am Soc Clin Oncol Educ Book 2018 May;38:708-715

From the University of Michigan, Ann Arbor, MI; University of Colorado Cancer Center, Denver, CO; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_209089DOI Listing
May 2018

Small-cell transformation of -rearranged non-small-cell adenocarcinoma of the lung.

Cold Spring Harb Mol Case Stud 2018 04 2;4(2). Epub 2018 Apr 2.

Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont 05401, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880261PMC
April 2018

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

J Mol Diagn 2017 09 9;19(5):682-696. Epub 2017 Aug 9.

Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975628PMC
September 2017

Dramatic Response to Crizotinib in a Patient with Lung Cancer Positive for an Gene Fusion.

JCO Precis Oncol 2017 29;2017(1). Epub 2017 Aug 29.

Department of Pathology, University of Colorado - Anschutz Medical Campus, Aurora CO.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844276PMC
http://dx.doi.org/10.1200/PO.17.00117DOI Listing
August 2017

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 07 6;12(7):e85-e88. Epub 2017 Mar 6.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.020DOI Listing
July 2017

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2017 Mar 7;141(3):437-444. Epub 2016 Nov 7.

From the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota (Drs Roden, Aubry, and Yi); the Department of Pathology, University of Colorado, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology and Genomic Medicine, Methodist Hospital, Houston, Texas (Drs Barrios, Cagle, Ge, and Miller); the Department of Pathology, Mount Sinai Health System, Icahn School of Medicine, New York, New York (Dr Beasley); the Department of Pathology, University of São Paolo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); Département de Biopathologie, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, La Tronche, France (Dr Lantuejoul); the Department of Pathology, New York University Langone Medical Center, New York, New York (Dr Moreira); the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Dr Smith); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0459-SADOI Listing
March 2017

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.

J Thorac Oncol 2016 08 9;11(8):1273-1281. Epub 2016 Apr 9.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961521PMC
August 2016

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Aug 19;140(8):825-9. Epub 2016 May 19.

From the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York, New York, and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, France, and J Fourier University-INSERM U 823-Institut A Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, VU Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0163-SADOI Listing
August 2016

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.

Lung Cancer 2016 06 26;96:27-32. Epub 2016 Mar 26.

Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.03.007DOI Listing
June 2016

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Apr 15. Epub 2016 Apr 15.

From the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York (Drs Borczuk and Cagle); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, University Health Network, Princess Margaret Cancer Centre, and the University of Toronto, Toronto, Ontario, Canada (Drs da Cunha Santos and Tsao); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School, and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, and J Fourier University, Institut National de la Santé et de la Recherche Médicale-Institut Albert Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, New York University, New York (Dr Moreira); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston (Drs Sholl and Vivero); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0091-SADOI Listing
April 2016

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

J Thorac Oncol 2016 Mar 24;11(3):414-9. Epub 2015 Dec 24.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698879PMC
March 2016

A Suggested Molecular Pathology Curriculum for Residents: A Report of the Association for Molecular Pathology.

J Mol Diagn 2016 Mar 5;18(2):153-62. Epub 2016 Feb 5.

Molecular Pathology Curriculum for Residents Task Force of the Association for Molecular Pathology Training & Education Committee, Bethesda, Maryland; Molecular Diagnostics Laboratory, Emory University Hospital, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.10.006DOI Listing
March 2016

Targeting the WNT Signaling Pathway in Cancer Therapeutics.

Oncologist 2015 Oct 25;20(10):1189-98. Epub 2015 Aug 25.

Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; Division of Medical Oncology and Department of Pathology, University of Colorado Denver, Aurora, Colorado, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591954PMC
October 2015

Rearranging Detection of Gene Rearrangements.

J Thorac Oncol 2015 Aug;10(8):1129-30

*Department of Pathology, and †Department of Medicine, Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000603DOI Listing
August 2015

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.

J Neuropathol Exp Neurol 2015 Jul;74(7):743-54

From the Molecular Oncology Research Center (APB, ACC, AP, RMR), and Department of Pathology (CSN), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Cancer Center (JS, DLA), and School of Medicine (EM, MVG), University of Colorado, Aurora, Colorado; Department of Neurosurgery(CC), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Surgery (RSO), and Department of Pathology and Forensic Medicine (APB, LN), Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP), São Paulo, Brazil; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho (RMR), Braga, Portugal; and ICVS/3B's - PT Government Associate Laboratory(RMR), Braga/Guimarães, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0000000000000213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470527PMC
July 2015

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.

Am J Surg Pathol 2015 Apr;39(4):528-40

Departments of *Pathology †Neurosurgery ‡Neurology §Pediatrics, The University of Colorado School of Medicine ∥Children's Hospital Colorado, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617316PMC
April 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

Giant pulmonary chondroid hamartoma: imaging and pathology correlation of a rare tumor demonstrated with bone scintigraphy and 18F-FDG PET/CT.

Clin Nucl Med 2015 Jan;40(1):79-81

From the Departments of *Radiology, and †Pathology, University of Colorado School of Medicine, Aurora, CO; ‡Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD; and §Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000599DOI Listing
January 2015

EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapy.

Clin Lung Cancer 2014 Sep 15;15(5):387-9. Epub 2014 May 15.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160348PMC
September 2014

Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Am J Clin Pathol 2014 Aug;142(2):254-60

From the Department of Pathology, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO; Department of Neurosurgery, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO; and Department of Neurology, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPIBSV67UVJRQVDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616006PMC
August 2014

Is there clinical value to prognostic signatures in early-stage NSCLC?

Clin Cancer Res 2014 Apr 28;20(7):1727-9. Epub 2014 Feb 28.

Authors' Affiliations: Division of Medical Oncology, Departments of Medicine and Pathology, University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998101PMC
April 2014

Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer.

J Thorac Oncol 2014 Mar;9(3):e21-3

*Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, People's Republic of China; †Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado; and ‡Department of Pathology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153022
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117236PMC
March 2014

The diagnostic efficacy of combining bronchoscopic tissue biopsy and endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of malignant lesions in the lung.

Diagn Cytopathol 2013 Nov 23;41(11):929-35. Epub 2012 Feb 23.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22847DOI Listing
November 2013

Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.

J Thorac Oncol 2013 Sep;8(9):e83-4

Departments of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829ceb8dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154819PMC
September 2013

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Am J Surg Pathol 2013 May;37(5):685-98

Department of Pathology, The University of Colorado Health Sciences Center, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31827f9c5eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610349PMC
May 2013

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.

Cancer 2013 Apr 20;119(8):1467-77. Epub 2012 Dec 20.

Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935240PMC
April 2013

Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

J Neurooncol 2013 Jan 25;111(1):59-69. Epub 2012 Oct 25.

Department of Pathology, The University of Colorado Health Sciences Center, 12605 E. 16th Avenue, Room 3026, MS F768, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0991-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617340PMC
January 2013

Molecular Pathology of Non-Small Cell Lung Cancer.

Surg Pathol Clin 2012 Dec 30;5(4):903-18. Epub 2012 Sep 30.

Department of Pathology, University of Colorado Denver, 12631 E. 17th Avenue, Mail Stop B216, Aurora, CO 80045, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2012.08.006DOI Listing
December 2012

Molecular pathology of non-small cell lung cancer: a practical guide.

Am J Clin Pathol 2012 Sep;138(3):332-46

Department of Pathology, University of Colorado, Anschutz Medical Campus, 12801 East 17th Ave, Mail Stop 8104, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPFR12WJKCEEZZDOI Listing
September 2012

The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.

Diagn Cytopathol 2012 Jun;40(6):511-24

Department of Pathology, Colorado Molecular Correlates Laboratory, University of Colorado Denver, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22820DOI Listing
June 2012

Prognostic patterns in the histopathology of pulmonary adenocarcinoma.

J Clin Oncol 2012 May 5;30(13):1401-3. Epub 2012 Mar 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.3964DOI Listing
May 2012

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

Clin Cancer Res 2012 Mar 10;18(5):1472-82. Epub 2012 Jan 10.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80209, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311875PMC
March 2012

Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization.

Am J Surg Pathol 2011 Dec;35(12):1894-901

Department of Pathology, Anschutz Medical Campus, University of Colorado, Denver, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3182382a3fDOI Listing
December 2011

Genetic testing for metastasis: potential for improved cancer treatment.

Future Oncol 2011 Jun;7(6):697-701

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.11.48DOI Listing
June 2011

Loss of S100 antigenicity in metastatic melanoma.

Hum Pathol 2005 Sep;36(9):1016-9

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2005.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656365PMC
September 2005

Telomerase regulation: not just flipping the switch.

Curr Opin Genet Dev 2002 Feb;12(1):80-5

The University of Texas Southwestern Medical Center, The Department of Cell Biology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9039, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0959-437x(01)00268-4DOI Listing
February 2002